Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking

Dec 23 2020

• By Ryan Nelson

Class Action Lawsuit Documents Envelope 3d Illustration

Related Content

Kirkman Acquires Rose, IQ Recalls Picamilon Supplement: Health And Wellness Industry News Roundup

Feb 07 2017

CV Sciences Eagerly Anticipating FDA Rulemaking On CBD In Dietary Supplements

May 01 2020

Plaintiff Claims Against Beiersdorf For ‘Unlawfully Marketed Drug’ Are Preempted By FDCA, Court Rules

Apr 24 2020

Additional Topics

United States Legal Issues Cannabidiol CBD Advertising, Marketing & Sales Commercial Dietary Supplements Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window